Luo Dan-Dan, Li Xi-Wen, Zhang Xiao-Can, Gu Ting, Li Hai-Feng, Duan Bao-Zhong
College of Pharmaceutical Science, Dali University, Dali 671000, China.
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Zhongguo Zhong Yao Za Zhi. 2017 Mar;42(5):989-997. doi: 10.19540/j.cnki.cjcmm.20170217.003.
The study aims to analyze the varieties and standards of compositae medicinal plants used in Dai medicine. The results showed that there were 78 species (including varieties) compositae plants recorded in literatures, which belongs to 63 medicinal materials varieties. And 47 original plants (60.25%) were recorded in Chinese medicinal material standards. In those standards and literatures of Dai medicine, there are great differences in translated Chinese names, original plants, medicinal parts, and efficacy of medicinal plants. Therefore, the variety systematization and the quality standards of Dai medicine should be strengthened.
该研究旨在分析傣药中使用的菊科药用植物的品种和标准。结果表明，文献记载的菊科植物有78种（含变种），隶属于63个药材品种。其中47种原植物（占60.25%）被载入《中国药材标准》。在傣药的这些标准和文献中，药用植物的中文名、原植物、药用部位及功效等方面存在较大差异。因此，应加强傣药品种的系统化和质量标准建设。
